US Broker Ratings

Charles River Laboratories (CRL) Stock Report: Analyst Consensus and 20% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. This Massachusetts-based company is known for its..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a Promising 11.54% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), an innovative player in the biotechnology sector, is catching investor attention with its promising growth trajectory and a potential upside of 11.54%. Headquartered in Dublin,..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: A 33.82% Upside Potential Beckons in the Biotech Sector

Ionis Pharmaceuticals, Inc. (IONS), a key player in the biotechnology sector, is commanding attention from investors with a market cap of $12.44 billion. Known for its pioneering RNA-targeted medicines, Ionis..

Vertex Pharmaceuticals (VRTX) Stock Report: Analyzing a 29.33% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a beacon in the biotechnology sector, with a market capitalization of $107.83 billion. Known for its groundbreaking treatments for serious diseases, Vertex has..

Insmed Incorporated (INSM): Analyst Consensus Signals a Potential 59.61% Upside for Investors

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline of therapies for serious and rare diseases. With..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 39.59% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian powerhouse in the healthcare industry, stands out as a compelling investment opportunity with a notable potential upside of 39.59%. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 9.04% Upside Amidst Healthcare Sector Dynamics

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, remains a focal point for investors seeking exposure in the medical instruments and supplies industry. With a market capitalization..

Waystar Holding Corp. (WAY) Stock Analysis: A 68% Upside Potential Awaits Investors

Waystar Holding Corp. (NASDAQ: WAY), a burgeoning player in the healthcare information services sector, presents an intriguing opportunity for investors seeking growth in the tech-driven healthcare domain. With a market..

Agilent Technologies, Inc. (A) Stock Analysis: A Promising 40% Upside Potential for Investors

Agilent Technologies, Inc. (NYSE: A) has long been a stalwart in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $32.36 billion, this American..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 26% Upside Potential in the Healthcare Sector

For investors keeping an eye on the healthcare sector, Intuitive Surgical, Inc. (NASDAQ: ISRG) presents a compelling opportunity. With a market capitalization of $162.13 billion, this leader in medical instruments..

Merit Medical Systems, Inc. (MMSI): Investor Outlook on a Potential 46% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leader in the healthcare sector specializing in the design and production of single-use medical products, presents a compelling investment opportunity with a potential..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 33.72% Potential Upside for Investors

Investors with an eye on the healthcare sector would do well to consider Stryker Corporation (NYSE: SYK), a leading player in the medical devices industry with a market capitalization of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a Potential 18.85% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking exposure to the orthopedic and reconstructive..

Solventum Corporation (SOLV) Stock Analysis: Unraveling a 26% Upside Potential in the Healthcare Sector

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is drawing attention from investors with its robust presence in the medical instruments and supplies industry. Headquartered in Eagan,..

BridgeBio Pharma (BBIO) Stock Analysis: Exploring a 47.59% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands at the forefront of the biotechnology industry, captivating investor attention with its innovative approach to treating genetic diseases. With a staggering market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Uncovering a Potential 40.88% Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) stands out as a promising player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of $13.25..

IDEXX Laboratories (IDXX) Investor Outlook: Unpacking a 27.67% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its impressive market presence and growth..

Repligen Corporation (RGEN): Analyst Consensus Highlights Strong Buy Ratings and 53% Potential Upside

For investors with a keen eye on the healthcare sector, Repligen Corporation (NASDAQ: RGEN) presents a compelling case. With a market capitalization of $6.61 billion, this U.S.-based life sciences company..

Danaher Corporation (DHR) Stock Analysis: Promising 42.81% Upside According to Analysts

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, stands poised for a potential upswing. With a market capitalization of $123.97 billion, Danaher operates in the diagnostics and..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a 51.79% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) presents an intriguing opportunity for investors with a knack for biotechnology stocks. With a market capitalization of $39.51 billion, this U.S.-based biopharmaceutical company is at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds